Alzheimer's Drug
-
FDA approves new Alzheimer’s drug that slows memory declineA key differentiating factor for donanemab is the drug's finite dosing, which allows patients to stop taking the treatment once brain scans no longer show amyloid plaques.HealthJul 3, 2024
-
Decision on Eli Lilly’s Alzheimer’s drug delayed by U.S. FDAThe U.S. Food and Drug Administration has delayed its decision on Eli Lilly's LLY.N experimental treatment for early Alzheimer's disease.HealthMar 8, 2024
-
-
Advertisement
-
Drug to treat agitation in Alzheimer’s patients approved in CanadaHealth Canada has approved an oral drug to treat symptoms of agitation associated with dementia due to Alzheimer’s disease in patients.CanadaJan 25, 2024
-
-
Advertisement
-
1st signs of Alzheimer’s may be detected in your eyes. This AI scan may help find itThe relentless pursuit of detecting Alzheimer's has posed a grueling battle for families and the medical community, but a simple eye scan may help ease that burden.HealthJul 19, 2023
-
Alzheimer’s drug slows progression in patients. It may soon be approved in U.S.Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.HealthJul 17, 2023
-
-
Experimental Alzheimer’s drug slows disease, researchers say. Will it make a difference?An experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening, researchers reported Tuesday.HealthNov 30, 2022
-
-
Alzheimer’s drug shows signs of slowing disease in early results of global studyEisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer's.HealthSep 29, 2022
-
U.S. drugmaker Lilly to submit ‘breakthrough’ Alzheimer’s drug to FDAThe drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year.HealthJun 24, 2021
-
-
Advertisement
-
U.S. FDA approves 1st new Alzheimer’s drug in nearly 20 yearsIt's the only drug that U.S. regulators have said can likely treat the underlying disease, rather than manage symptoms like anxiety and insomnia.HealthJun 7, 2021
-
-
Advertisement
-
Company pushes Alzheimer’s drug amid conflicting resultsAducanumab's developers stopped two studies earlier this year because it didn’t seem to be working, then did a stunning about-face in October and said new results suggest it was effective at a high dose.ScienceDec 5, 2019
Trending
-
Latest GST/HST credit payments to roll out. How much could Canadians get?3,393 Read
-
‘She will be deeply missed’: Mom of 3, school teacher identified as Calgary double homicide victim1,826 Read
-
Tax changes are coming in 2025. Here’s what Canadians need to know1,552 Read
-
Is alcohol shortening your life? An online tool built in B.C. will tell you1,378 Read
-
As Meghan Markle returns to Instagram, fans spot relatable social media gaffe1,024 Read
-
Squirrel-chasing dog defies gravity with 50-foot tree climb in Alberta937 Read
-
Top Videos
-
Boxing Day blowout: Is the ‘HST-GST holiday’ causing shoppers to spend more?49 Viewed
-
Cost of living top of mind for Canadians in 2024, poll finds34 Viewed
-
Montreal man is $40M richer thanks to Lotto Max win23 Viewed
-
‘This is evil’: Driver rams into New Orleans crowd, killing at least 1523 Viewed
-
Business Matters: ‘Tax holiday’ boosting sales despite some struggles, industry groups say23 Viewed
-
Athabasca RCMP dismantle multi-million dollar chop shop15 Viewed
-